Search Results For :: patient flow
-
Biosimilars Market by Drug Class (mAbs [Adalimumab, Infliximab, Rituximab, Trastuzumab], GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2036
The global biosimilars market is projected to reach USD 70.79 billion by 2036, growing at a CAGR of 6.6% during the forecast period (2026–2036). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015)
The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.
- Published: November 2010
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Service), Type (Safety, Efficacy, Validation), Research Area (Genomics, Proteomics), Technology (PCR, NGS, MS), Disease (Cancer, CVD), Application (Diagnostic, Drug Discovery) - Global Forecast to 2031
The global biomarkers market is projected to reach USD 112.10 billion by 2031, growing at a CAGR of 10.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
A2P Messaging Market by Application (Authentication Services, Promotional & Marketing Services, Customer Relationship Management Services, Pushed Content Services, Interactive Messaging Services, Notification & Alerts) - Global Forecast to 2029
The A2P messaging market size is projected to reach USD 84.8 billion by 2029, at a CAGR of 3.0% during the forecast period. The A2P messaging market comprises major providers, such as AT&T (US), China Mobile (China), Sinch (Sweden), Twilio (US), Infobip (UK), Vonage (US), Orange (France), Comviva (India), Route Mobile (India), BICS (Belgium), Monty Mobile (UK), Tata Communications (India), Syniverse (US), Tyntec (UK), Soprano Design (Australia), Genesys (US), Clickatell (US), CEQUENS (Egypt), MSG91 (India), Plivo (US), Mitto (Switzerland), Bird (Netherlands), Telewhale (Cyprus), EnableX.io (Singapore), TextUs (US), Voxvalley (Singapore). To increase their market share in the A2P messaging industry, these competitors have used a variety of growth methods, including partnerships, agreements, collaborations, new product releases, product enhancements, and acquisitions.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Cell Source (Adipose Tissue, Bone Marrow, Placenta, Umbilical Cord, iPSC), Type (Autologus Stem Cell), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological), End User - Global Forecast to 2035
The global stem cell therapy market is projected to reach USD 3.65 billion by 2035, growing at a CAGR of 25.3% during the forecast period (2026–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Cardiac Monitoring & Rhythm Management Devices Market by Type [Cardiac Monitoring (ECG, Ambulatory Monitors), Cardiac Rhythm Management [Pacemaker (Single, Leadless), Defibrillator (AED)], Application [Arrhythmia], End User [Hospital] - Global Forecast to 2031
The global cardiac monitoring and cardiac rhythm management devices market, valued at USD 26.33 billion in 2025, stood at USD 27.90 billion in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 37.88 billion by the end of the period. The market is growing overall due to the rising prevalence of cardiovascular diseases and arrhythmias, driven largely by an aging global population and increasing lifestyle-related risk factors such as obesity and diabetes.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Long Term Evolution (LTE) Market (2010-2015) By Infrastructure (E-Utran, E Node B, EPC), End-User Devices (Smartphones, USB Modems, Card Modules, Netbooks) & Services
The need for mobile broadband is growing everyday as digital lifestyle continues to evolve with the line between cell phones, mobile handheld devices, PCs and laptops getting blurred. Users continue to show increasing interest for real time applications that include video-conferencing, publishing and social networking. Subscriber’s interest in accessing high bandwidth applications such as YouTube from their mobile phones are further taxing the already stressed networks of mobile service providers. To meet this increasing demand for bandwidth, operators are migrating to LTE, which provides them with an opportunity to introduce new services such as data download, accessing internet from mobiles and ultimately helping them to improve their bottom-line.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Probiotics Market Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030
The global probiotics market is estimated to be valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Global Machine Vision and Vision Guided Robotics Market (2010 - 2015)
The report reviews important developments in the markets for robotic vision hardware and software. It analyzes the market drivers, challenges and restraints in machine vision and 3D vision-guided robots in industrial automation and its applications.
- Published: May 2011
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 60
